Annual SGA
$269.44 M
+$14.93 M+5.86%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual SGA is $269.44 million, with the most recent change of +$14.93 million (+5.86%) on December 31, 2023.
- During the last 3 years, PCRX annual SGA has risen by +$75.92 million (+39.23%).
- PCRX annual SGA is now at all-time high.
Performance
PCRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$74.33 M
+$6.21 M+9.11%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly SGA is $74.33 million, with the most recent change of +$6.21 million (+9.11%) on September 30, 2024.
- Over the past year, PCRX quarterly SGA has increased by +$6.39 million (+9.40%).
- PCRX quarterly SGA is now at all-time high.
Performance
PCRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$505.94 M
-$90.73 M-21.85%
September 30, 2024
Summary
- As of February 7, 2025, PCRX TTM SGA is -$505.94 million, with the most recent change of -$90.73 million (-21.85%) on September 30, 2024.
- Over the past year, PCRX TTM SGA has dropped by -$773.55 million (-289.06%).
- PCRX TTM SGA is now -360.94% below its all-time high of -$109.76 million.
Performance
PCRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PCRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.9% | +9.4% | -289.1% |
| 3 y3 years | +39.2% | +15.7% | -335.2% |
| 5 y5 years | +52.0% | +15.7% | -335.2% |
PCRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.2% | at high | +42.5% | -21.9% | +42.9% |
| 5 y | 5-year | at high | +39.2% | at high | +71.5% | -21.9% | +68.0% |
| alltime | all time | at high | +5267.4% | at high | +7252.4% | -360.9% | +68.0% |
Pacira BioSciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $74.33 M(+9.1%) | $280.29 M(+2.3%) |
| Jun 2024 | - | $68.13 M(-5.4%) | $273.90 M(+1.2%) |
| Mar 2024 | - | $72.03 M(+9.5%) | $270.62 M(+0.4%) |
| Dec 2023 | $269.44 M(+5.9%) | $65.80 M(-3.2%) | $269.44 M(+0.7%) |
| Sep 2023 | - | $67.95 M(+4.8%) | $267.61 M(+2.6%) |
| Jun 2023 | - | $64.85 M(-8.5%) | $260.95 M(-0.1%) |
| Mar 2023 | - | $70.84 M(+10.7%) | $261.10 M(+2.6%) |
| Dec 2022 | $254.52 M(+27.7%) | $63.97 M(+4.4%) | $254.52 M(+4.9%) |
| Sep 2022 | - | $61.28 M(-5.7%) | $242.70 M(+5.9%) |
| Jun 2022 | - | $65.00 M(+1.2%) | $229.27 M(+6.6%) |
| Mar 2022 | - | $64.26 M(+23.2%) | $215.08 M(+7.9%) |
| Dec 2021 | $199.34 M(+3.0%) | $52.15 M(+9.0%) | $199.34 M(-0.3%) |
| Sep 2021 | - | $47.86 M(-5.8%) | $200.02 M(-2.3%) |
| Jun 2021 | - | $50.81 M(+4.7%) | $204.73 M(+3.8%) |
| Mar 2021 | - | $48.52 M(-8.2%) | $197.26 M(+1.9%) |
| Dec 2020 | $193.52 M(-3.6%) | $52.83 M(+0.5%) | $193.52 M(-0.7%) |
| Sep 2020 | - | $52.56 M(+21.3%) | $194.91 M(+1.3%) |
| Jun 2020 | - | $43.34 M(-3.2%) | $192.47 M(-2.9%) |
| Mar 2020 | - | $44.78 M(-17.4%) | $198.26 M(-1.3%) |
| Dec 2019 | $200.78 M(+13.3%) | $54.22 M(+8.2%) | $200.78 M(+5.0%) |
| Sep 2019 | - | $50.13 M(+2.0%) | $191.21 M(+3.2%) |
| Jun 2019 | - | $49.13 M(+3.8%) | $185.26 M(+2.7%) |
| Mar 2019 | - | $47.30 M(+6.0%) | $180.38 M(+1.8%) |
| Dec 2018 | $177.26 M(+9.8%) | $44.65 M(+1.1%) | $177.26 M(+3.2%) |
| Sep 2018 | - | $44.18 M(-0.2%) | $171.80 M(+2.1%) |
| Jun 2018 | - | $44.25 M(+0.1%) | $168.26 M(+2.9%) |
| Mar 2018 | - | $44.19 M(+12.8%) | $163.56 M(+1.3%) |
| Dec 2017 | $161.49 M(+5.8%) | $39.18 M(-3.6%) | $161.49 M(+2.9%) |
| Sep 2017 | - | $40.64 M(+2.8%) | $156.99 M(+2.8%) |
| Jun 2017 | - | $39.55 M(-6.1%) | $152.66 M(-2.6%) |
| Mar 2017 | - | $42.12 M(+21.5%) | $156.78 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $152.61 M(+9.8%) | $34.67 M(-4.5%) | $152.61 M(-1.9%) |
| Sep 2016 | - | $36.31 M(-16.8%) | $155.49 M(+0.6%) |
| Jun 2016 | - | $43.67 M(+15.0%) | $154.49 M(+6.1%) |
| Mar 2016 | - | $37.96 M(+1.1%) | $145.57 M(+4.7%) |
| Dec 2015 | $139.04 M(+30.4%) | $37.55 M(+6.4%) | $139.04 M(+4.9%) |
| Sep 2015 | - | $35.31 M(+1.6%) | $132.51 M(+5.7%) |
| Jun 2015 | - | $34.75 M(+10.6%) | $125.42 M(+8.6%) |
| Mar 2015 | - | $31.43 M(+1.3%) | $115.50 M(+8.3%) |
| Dec 2014 | $106.66 M(+70.6%) | $31.02 M(+9.9%) | $106.66 M(+11.3%) |
| Sep 2014 | - | $28.22 M(+13.6%) | $95.81 M(+15.6%) |
| Jun 2014 | - | $24.84 M(+10.0%) | $82.92 M(+14.9%) |
| Mar 2014 | - | $22.59 M(+12.0%) | $72.16 M(+15.4%) |
| Dec 2013 | $62.51 M(+35.0%) | $20.17 M(+31.7%) | $62.51 M(+12.2%) |
| Sep 2013 | - | $15.32 M(+8.8%) | $55.70 M(+7.6%) |
| Jun 2013 | - | $14.08 M(+8.8%) | $51.76 M(+7.6%) |
| Mar 2013 | - | $12.94 M(-3.2%) | $48.09 M(+3.9%) |
| Dec 2012 | $46.31 M(+129.7%) | $13.36 M(+17.4%) | $46.31 M(+15.4%) |
| Sep 2012 | - | $11.38 M(+9.3%) | $40.14 M(+19.0%) |
| Jun 2012 | - | $10.41 M(-6.6%) | $33.74 M(+21.4%) |
| Mar 2012 | - | $11.15 M(+54.9%) | $27.79 M(+37.8%) |
| Dec 2011 | $20.16 M(+216.6%) | $7.20 M(+44.8%) | $20.16 M(+31.1%) |
| Sep 2011 | - | $4.97 M(+11.3%) | $15.38 M(+27.1%) |
| Jun 2011 | - | $4.47 M(+26.8%) | $12.10 M(+36.4%) |
| Mar 2011 | - | $3.52 M(+45.6%) | $8.87 M(+39.5%) |
| Dec 2010 | $6.37 M(+26.8%) | $2.42 M(+42.8%) | $6.36 M(+26.2%) |
| Sep 2010 | - | $1.69 M(+36.8%) | $5.04 M(+2.1%) |
| Jun 2010 | - | $1.24 M(+22.5%) | $4.94 M(+33.4%) |
| Mar 2010 | - | $1.01 M(-8.1%) | $3.70 M(+37.6%) |
| Dec 2009 | $5.02 M(-41.7%) | $1.10 M(-30.9%) | $2.69 M(+69.1%) |
| Sep 2009 | - | $1.59 M | $1.59 M |
| Dec 2008 | $8.61 M | - | - |
FAQ
- What is Pacira BioSciences annual SGA?
- What is the all time high annual SGA for Pacira BioSciences?
- What is Pacira BioSciences annual SGA year-on-year change?
- What is Pacira BioSciences quarterly SGA?
- What is the all time high quarterly SGA for Pacira BioSciences?
- What is Pacira BioSciences quarterly SGA year-on-year change?
- What is Pacira BioSciences TTM SGA?
- What is the all time high TTM SGA for Pacira BioSciences?
- What is Pacira BioSciences TTM SGA year-on-year change?
What is Pacira BioSciences annual SGA?
The current annual SGA of PCRX is $269.44 M
What is the all time high annual SGA for Pacira BioSciences?
Pacira BioSciences all-time high annual SGA is $269.44 M
What is Pacira BioSciences annual SGA year-on-year change?
Over the past year, PCRX annual SGA has changed by +$14.93 M (+5.86%)
What is Pacira BioSciences quarterly SGA?
The current quarterly SGA of PCRX is $74.33 M
What is the all time high quarterly SGA for Pacira BioSciences?
Pacira BioSciences all-time high quarterly SGA is $74.33 M
What is Pacira BioSciences quarterly SGA year-on-year change?
Over the past year, PCRX quarterly SGA has changed by +$6.39 M (+9.40%)
What is Pacira BioSciences TTM SGA?
The current TTM SGA of PCRX is -$505.94 M
What is the all time high TTM SGA for Pacira BioSciences?
Pacira BioSciences all-time high TTM SGA is -$109.76 M
What is Pacira BioSciences TTM SGA year-on-year change?
Over the past year, PCRX TTM SGA has changed by -$773.55 M (-289.06%)